Highside Capital Management: Funding, Team & Investors | Startup Intros

Loading organizations...

Highside Capital Management: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 1, 2021	Mythic Therapeutics	$100.0M Series B	Viking Global Investors	Curie.Bio, First Round Capital, F-Prime Capital Partners, i/o Ventures, Meridian Street Capital, Moderne Ventures, Niu Ventures, Operator Partners, Refactor Capital, SV Angel, Threshold Ventures, Transformation Capital, Venrock, Venture Catalysts \| India's First Integrated Incubator, Aaron Patzer, Jonathan Bush, Kevin Nazemi, Vivek Garipalli, Foresite Capital, LifeForce Capital, OMX Ventures, Perceptive Advisors
Aug 1, 2021	InterVenn	$200.0M Series C	Heritage Provider Network, Highside Capital Management, Irving Investors, SoftBank	Amplify Partners, Anzu Partners, Genoa Ventures, Mango Capital, NFX, Northpond Ventures, Outlier Ventures, Redpoint Ventures, True Ventures, Uncork Capital, Adam Gross, Amit Agarwal, Gerhard Eschelbeck, Spencer Kimball, Stani Kulechov
Jul 29, 2021	Strata Oncology	$90.0M Series C	Wellington Management	Arboretum Ventures, Baird Capital, Cormorant Asset Management, Deerfield Management, Merck, Monashee Investment Management, Renaissance Venture Capital Fund
Jun 4, 2020	Athira Pharma	$85.0M Series B	Joseph Edelman	Richard Kayne, suzanne kayne, Avidity Partners, Franklin Templeton, Janus Henderson Investors, LifeSci Venture Partners, Logos Capital, Rock Springs Capital, RTW Investments, Sahsen Ventures, Sofinnova Ventures, Surveyor Capital, Venrock, Viking Global Investors